Czechia· CZ-0219442

SOLICARE

A solifenacin product containing solifenacin succinate, registered in Czechia by CANDE CZ s.r.o., Praha. The same ATC class is registered in 18 of our 19 countries.

ATC G04BD08

Checked against SÚKL (Czech Republic) on

Informational only — not a medical device.

SOURCE REGISTER · CZSÚKL (Czech Republic)normalisedSOLICAREATCG04BD08REGISTER NO.CZ-0219442PACKS LISTED0CHECKEDSeptember 28, 2026

Where it is registered

Solifenacin is registered in 18 of 19 countries.

Countries holding a registration under ATC G04BD08 (solifenacin), each read from that country’s own register.

  • This record: Czechia, from SÚKL (Czech Republic)
  • 11 of them publish a price we can compare per daily dose

Solifenacin · ATC G04BD08

18 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of solifenacin costs, country by country.

Normalised to the WHO defined daily dose (5 mg), the median price runs from $0.25 in France to $0.92 in Switzerland — a ×3.7 gap.

  • 4 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Solifenacin · price per daily dose (5 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.92
  • ES Spain$0.77
  • IT Italy$0.59
  • FR France$0.25
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

SÚKL (Czech Republic)
Active substance
SOLIFENACIN SUCCINATE
Manufacturer
CANDE CZ s.r.o., Praha
Country
Czechia (CZ)
ATC code
G04BD08
ATC class
Solifenacin
Defined daily dose
5 mg, O
Reimbursed
Not published by this register
Source register
SÚKL (Czech Republic)
Last checked
September 28, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

315 interactions on record for solifenacin.

Graded by severity as the source publishes them — 50 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Solifenacin · interactions on record

315 records

  • 50 severe
  • 210 moderate
  • 3 minor

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • Potassium chlorideA12BA01severe

52 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Solifenacin in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All solifenacin products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Solifenacin +pharma, Solifenacin 1a Pharma
  • Belgium · Pelvicare, Solifenacin Ab
  • Bulgaria · Truzor, Асолфена
  • Cyprus · Saprax, Solifenacin Accord
  • Germany · Solifemin, Solifenacin 1 A Pharma
  • Denmark · Solifenacin "sandoz", Solifenacin Krka
  • Estonia · Asolfena, Solifenacin Nobel
  • Spain · Dicrisol, Sincal
  • Finland · Solifenacin Accord, Solifenacin Krka
  • France · Solifenacine Accord, Solifenacine Arrow
  • United Kingdom (Northern Ireland) · Seylacine Solifenacin Succinate, Solifenacin Jubilant Pharmaceuticals
  • Greece · Cecure, Nacerfin
  • Croatia · Asolfena, Beloflux
  • Hungary · Asolfena, Belsanor
  • Ireland · Solifenacin Clonmel, Solifenacin Succinate Accord Healthcare Ireland
  • Iceland · Solifenacin Alvogen, Solifenacin Krka
  • Italy · Incoves, Orodax
  • Liechtenstein · Vesicare
  • Lithuania · Asolfena, Gardurin
  • Luxembourg · Pelvicare, Solifenacin Ratiopharm
  • Latvia · Asolfena, Gardurin
  • Malta · Solifenacin Pharmsol, Vesicare
  • Netherlands · Solifenacinesuccinaat Accord, Solifenacinesuccinaat Aurobindo
  • Norway · Solifenacin Accord, Solifenacin Krka
  • Poland · Adablok, Afenix
  • Portugal · Blaxi, Solifenacina Alter
  • Romania · Asolfena, Solifenacin Msn Laboratories
  • Sweden · Solifenacin Accord, Solifenacin Glenmark
  • Slovenia · Asolfena, Solifenacin Lek
  • Slovakia · Aristissa, Arusol

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d410c896-d71d-43a2-acc1-c3369a04d2f3
GET /v1/drugs/d410c896-d71d-43a2-acc1-c3369a04d2f3?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "TBL FLM",
  "source": "sukl",
  "strength": "5MG",
  "pack_size": "100",
  "substance": "SOLIFENACIN SUCCINATE",
  "cz_kod_sukl": "0219442",
  "product_type": "CH",
  "substance_codes": "17227",
  "registration_state": "R",
  "registration_number": "73/187/17-C"
}

See everything about solifenacin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.